{
 "url": "https://etfiq.com/funds/lfsc/holdings/",
 "section": "funds",
 "title": "LFSC Holdings: All 39 Positions (May 31, 2026) | ETFIQ",
 "description": "All 39 LFSC holdings with weights, as of May 31, 2026. The top 3 are TVTX 7.67%, COGT 7.53% and LIVN 7.11%. Download the full list as a CSV.",
 "as_of": "May 31, 2026",
 "ticker": "LFSC",
 "fund": "F/m Emerald Life Sciences Innovation ETF",
 "fund_page": "https://etfiq.com/funds/lfsc",
 "positions": 39,
 "positions_listed_on_page": 39,
 "lead": "LFSC held 39 positions as of May 31, 2026. Travere Therapeutics Inc is the largest at 7.67%; the top 10 are 54.7% of the fund.",
 "source": {
  "name": "Form N-PORT filed with the SEC",
  "url": "https://www.sec.gov/Archives/edgar/data/831114/000119312526319618/primary_doc.xml",
  "document": "the fund’s SEC filing",
  "book_date": "2026-05-31",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Travere Therapeutics Inc",
   "ticker": "TVTX",
   "weight_pct": 7.666,
   "page": "https://etfiq.com/holdings/tvtx/"
  },
  {
   "rank": 2,
   "holding": "Cogent Biosciences Inc",
   "ticker": "COGT",
   "weight_pct": 7.525,
   "page": "https://etfiq.com/holdings/cogt/"
  },
  {
   "rank": 3,
   "holding": "LivaNova PLC",
   "ticker": "LIVN",
   "weight_pct": 7.11,
   "page": "https://etfiq.com/holdings/livn/"
  },
  {
   "rank": 4,
   "holding": "Spyre Therapeutics Inc",
   "ticker": "SYRE",
   "weight_pct": 6.407,
   "page": "https://etfiq.com/holdings/syre/"
  },
  {
   "rank": 5,
   "holding": "Guardant Health Inc",
   "ticker": "GH",
   "weight_pct": 5.517,
   "page": "https://etfiq.com/holdings/gh/"
  },
  {
   "rank": 6,
   "holding": "Mirum Pharmaceuticals Inc",
   "ticker": "MIRM",
   "weight_pct": 4.919,
   "page": "https://etfiq.com/holdings/mirm/"
  },
  {
   "rank": 7,
   "holding": "Corcept Therapeutics Inc",
   "ticker": "CORT",
   "weight_pct": 4.792,
   "page": "https://etfiq.com/holdings/cort/"
  },
  {
   "rank": 8,
   "holding": "United Therapeutics Corp",
   "ticker": "UTHR",
   "weight_pct": 4.156,
   "page": "https://etfiq.com/holdings/uthr/"
  },
  {
   "rank": 9,
   "holding": "VeraDermics Inc",
   "ticker": "MANE",
   "weight_pct": 3.416,
   "page": null
  },
  {
   "rank": 10,
   "holding": "Savara Inc",
   "ticker": "SVRA",
   "weight_pct": 3.222,
   "page": null
  },
  {
   "rank": 11,
   "holding": "Cytokinetics Inc",
   "ticker": "CYTK",
   "weight_pct": 3.161,
   "page": "https://etfiq.com/holdings/cytk/"
  },
  {
   "rank": 12,
   "holding": "Nektar Therapeutics",
   "ticker": "NKTR",
   "weight_pct": 3.142,
   "page": null
  },
  {
   "rank": 13,
   "holding": "Trevi Therapeutics Inc",
   "ticker": "TRVI",
   "weight_pct": 3.117,
   "page": null
  },
  {
   "rank": 14,
   "holding": "Dianthus Therapeutics Inc",
   "ticker": "DNTH",
   "weight_pct": 3.088,
   "page": "https://etfiq.com/holdings/dnth/"
  },
  {
   "rank": 15,
   "holding": "Axsome Therapeutics Inc",
   "ticker": "AXSM",
   "weight_pct": 2.84,
   "page": "https://etfiq.com/holdings/axsm/"
  },
  {
   "rank": 16,
   "holding": "Billiontoone Inc",
   "ticker": "BLLN",
   "weight_pct": 2.735,
   "page": null
  },
  {
   "rank": 17,
   "holding": "TransMedics Group Inc",
   "ticker": "TMDX",
   "weight_pct": 2.68,
   "page": "https://etfiq.com/holdings/tmdx/"
  },
  {
   "rank": 18,
   "holding": "Viridian Therapeutics Inc",
   "ticker": "VRDN",
   "weight_pct": 2.235,
   "page": "https://etfiq.com/holdings/vrdn/"
  },
  {
   "rank": 19,
   "holding": "ICU Medical Inc",
   "ticker": "ICUI",
   "weight_pct": 2.091,
   "page": "https://etfiq.com/holdings/icui/"
  },
  {
   "rank": 20,
   "holding": "Corvus Pharmaceuticals Inc",
   "ticker": "CRVS",
   "weight_pct": 1.953,
   "page": null
  },
  {
   "rank": 21,
   "holding": "Palvella Therapeutics Inc",
   "ticker": "PVLA",
   "weight_pct": 1.945,
   "page": null
  },
  {
   "rank": 22,
   "holding": "Ceribell Inc",
   "ticker": "CBLL",
   "weight_pct": 1.552,
   "page": null
  },
  {
   "rank": 23,
   "holding": "Globus Medical Inc",
   "ticker": "GMED",
   "weight_pct": 1.267,
   "page": "https://etfiq.com/holdings/gmed/"
  },
  {
   "rank": 24,
   "holding": "Xeris Biopharma Holdings Inc",
   "ticker": "XERS",
   "weight_pct": 1.217,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Bridgebio Pharma Inc",
   "ticker": "BBIO",
   "weight_pct": 1.169,
   "page": "https://etfiq.com/holdings/bbio/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.038
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/lfsc/holdings/lfsc-holdings.csv",
 "json_book": "https://etfiq.com/data/books/lfsc.json",
 "markdown": "https://etfiq.com/funds/lfsc/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of LFSC, data as of May 31, 2026. https://etfiq.com/funds/lfsc/holdings/"
}